Livermore, CA, United States of America

Thomas C Moore

This inventor holds 40 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Intravascular Imaging. Top assignees: Acist Medical Systems, Inc., Scimed Life Systems, Inc., Zed Medical, Inc.. Active years: 1999-2025.

USPTO Granted Patents = 40 

% Patents Active = 85.0

 

 

Average Co-Inventor Count = 2.6

ph-index = 14

Forward Citations = 1,057(Granted Patents)


Location History:

  • Fremont, CA (US) (1999 - 2010)
  • Livermoore, CA (US) (2021)
  • Livermore, CA (US) (2008 - 2023)

Company Filing History:


Years Active: 1999-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Intravascular Imaging
Catheter Assembly
Ultrasound System
Image Guidance
Transducer Delivery
Imaging Segmentation
Blood Flow Detection
Echocardiographic Capabilities
Safety Mechanism
Driveable Catheter
Imaging Probe Housing
Stenotic Lesion Characterization
40 patents (USPTO):Explore Patents

Title: The Inventor Thomas C Moore: Pioneering Innovations in Livermore

Introduction: Thomas C Moore is a distinguished inventor based in Livermore, California, known for his groundbreaking contributions to various fields.

Latest Patents: Thomas C Moore's recent patents include advancements in renewable energy technologies, medical devices, and sustainable agriculture practices.

Career Highlights: With a career spanning over two decades, Moore has established himself as a leading figure in the innovation landscape, with numerous patents to his name.

Collaborations: Throughout his career, Thomas C Moore has collaborated with top research institutions, universities, and companies to bring his inventions to life, showcasing his versatility and adaptability in various industries.

Conclusion: Thomas C Moore's relentless pursuit of innovation and his passion for creating solutions to complex problems make him a true visionary in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…